Insider · CIK 0001862147

Balcom Alexandra

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001862147

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−37.5K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−33.6K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−84.2K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc.A Award	Chief Financial Officer	AAward	+14.4K sh	—	—	14,350
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−132K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−17.5K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−14.4K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−22.9K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc.U Disposition from Tender	Chief Financial Officer	UDisposition from Tender	−44.4K sh	$124.00	−$5.51M	0
2026-07-15	NUVLNuvalent, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−41.1K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−8,016 sh	—	—	0
2026-07-01	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+6,046 sh	$18.93	+$114K	96,963
2026-07-01	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,384 sh	—	—	8,016
2026-07-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−11.4K sh	$123.58	−$1.41M	85,533
2026-07-01	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,384 sh	$6.89	+$37.1K	90,917
2026-07-01	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−6,046 sh	—	—	22,933
2026-06-02	CBIOCRESCENT BIOPHARMA, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+11.1K sh	—	—	11,050
2026-06-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−2,588 sh	$100.65	−$260K	86,012
2026-06-01	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−11.4K sh	—	—	13,400
2026-06-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−900 sh	$97.68	−$87.9K	92,933
2026-06-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−200 sh	$103.84	−$20.8K	85,533
2026-06-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−1,200 sh	$98.57	−$118K	91,733
2026-06-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−3,133 sh	$99.86	−$313K	88,600
2026-06-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−279 sh	$101.79	−$28.4K	85,733
2026-06-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−2,170 sh	$95.99	−$208K	93,833
2026-06-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−960 sh	$94.87	−$91.1K	96,003
2026-06-01	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+11.4K sh	$6.89	+$78.8K	96,963
2026-05-01	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,159 sh	—	—	131,637
2026-05-01	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,271 sh	$6.89	+$29.4K	96,963
2026-05-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−3,872 sh	$98.42	−$381K	93,091
2026-05-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−7,434 sh	$99.29	−$738K	85,657
2026-05-01	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,159 sh	$1.08	+$7,731.72	92,692
2026-05-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−124 sh	$99.97	−$12.4K	85,533
2026-05-01	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,271 sh	—	—	24,830
2026-04-01	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−11.4K sh	—	—	138,796
2026-04-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−2,469 sh	$106.18	−$262K	85,533
2026-04-01	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+11.4K sh	$1.08	+$12.3K	96,963
2026-04-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−3,544 sh	$104.39	−$370K	93,419
2026-04-01	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−5,417 sh	$105.30	−$570K	88,002
2026-03-25	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−13.7K sh	$100.16	−$1.37M	85,533
2026-03-24	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−1,160 sh	$96.50	−$112K	99,233
2026-03-24	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−11.4K sh	—	—	150,226
2026-03-24	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+11.4K sh	$1.08	+$12.3K	110,663
2026-03-24	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−2,599 sh	$95.03	−$247K	108,064
2026-03-24	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−7,671 sh	$95.88	−$735K	100,393
2026-01-07	NUVLNuvalent, Inc.A Award	Chief Financial Officer	AAward	+17.5K sh	—	—	99,233
2026-01-07	NUVLNuvalent, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+17.5K sh	—	—	17,500
2026-01-06	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−1,635 sh	$97.33	−$159K	81,958
2026-01-06	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−1,321 sh	$96.75	−$128K	83,593
2026-01-06	NUVLNuvalent, Inc.S Sale	Chief Financial Officer	SSale	−225 sh	$98.40	−$22.1K	81,733

Recent filings

Accepted (ET)
Jul 154
Balcom Alexandra0001193125-26-305094
SEC(opens sec.gov)
Jul 64
Balcom Alexandra0001862147-26-000009
SEC(opens sec.gov)
Jun 34
Balcom Alexandra0001862147-26-000007
SEC(opens sec.gov)

Companies

Address

C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR

CAMBRIDGE, MA, 02142